From the Sector

Reset
19.02.2026

INVISTA: Nancy Kowalski New President and CEO

Nancy Kowalski has been named new president and CEO of INVISTA, a Koch company, effective March 1, 2026. In this role, she’ll be responsible for continuing to adapt and improve business models across INVISTA, a global manufacturer of chemical intermediates, polymers and fibers used in parts for the automotive industry, medical equipment, airbags, food packaging and clothing.

Nancy has 22 years of expertise across INVISTA in a variety of its business lines and its global supply chain. She joined INVISTA as a director of corporate reporting in 2004 and went on to hold leadership roles in treasury, global finance and global supply chain.

She was most recently executive vice president for INVISTA’s global nylon business, with operations in China, Europe, and the United States, leading its overall profit and loss management and overseeing Nylon Sales and Marketing, the strategic management of feedstock procurement and purchasing processes for the company.

Nancy Kowalski has been named new president and CEO of INVISTA, a Koch company, effective March 1, 2026. In this role, she’ll be responsible for continuing to adapt and improve business models across INVISTA, a global manufacturer of chemical intermediates, polymers and fibers used in parts for the automotive industry, medical equipment, airbags, food packaging and clothing.

Nancy has 22 years of expertise across INVISTA in a variety of its business lines and its global supply chain. She joined INVISTA as a director of corporate reporting in 2004 and went on to hold leadership roles in treasury, global finance and global supply chain.

She was most recently executive vice president for INVISTA’s global nylon business, with operations in China, Europe, and the United States, leading its overall profit and loss management and overseeing Nylon Sales and Marketing, the strategic management of feedstock procurement and purchasing processes for the company.

After more than 30 years of service to Koch, Brook Vickery, president and CEO of INVISTA, has announced his retirement, effective March 1, 2026. Brook joined Koch in 1991 as an instrument engineer for Flint Hills Resources. He joined INVISTA as its global operations leader in 2023 and then became president and CEO in January 2025.

Brook has been fundamental in helping transform Koch’s operational models both at Flint Hills and INVISTA. His ability to build culture, apply Principle Based Management™, and deliver results and operational reliability will continue to create long-term value.

More information:
Invista CEO
Source:

Invista

Kraig Biocraft Laboratories Photo Kraig Biocraft Laboratories
17.02.2026

Kraig Activates First Wave of 2026 Production Program

Kraig Biocraft Laboratories, Inc., a global leader in spider silk technology*, announced that its 2026 production plan has officially moved from strategy to execution.
 
The Company has now moved bio-material to incubation, getting a jumpstart on its March production plan and formally initiating its multi-ton spider silk scale-up initiative.
 
This milestone follows Kraig’s recently announced 2026 production schedule. This aggressive plan is set to achieve sustained monthly production of recombinant spider silk cocoons at unprecedented commercial volumes. With the release of the first wave of production materials now complete, Kraig Labs has activated its expanded manufacturing pipeline and commenced field-level implementation.
 
"This is the moment where planning becomes production," said Kim Thompson, Kraig Labs CEO and Founder. "Our 2026 roadmap was built around disciplined expansion, operational efficiency, and multi-ton output. Today, that roadmap is in motion. Bio-materials have recently been moved to incubation in preparation for the March production run."
 

Kraig Biocraft Laboratories, Inc., a global leader in spider silk technology*, announced that its 2026 production plan has officially moved from strategy to execution.
 
The Company has now moved bio-material to incubation, getting a jumpstart on its March production plan and formally initiating its multi-ton spider silk scale-up initiative.
 
This milestone follows Kraig’s recently announced 2026 production schedule. This aggressive plan is set to achieve sustained monthly production of recombinant spider silk cocoons at unprecedented commercial volumes. With the release of the first wave of production materials now complete, Kraig Labs has activated its expanded manufacturing pipeline and commenced field-level implementation.
 
"This is the moment where planning becomes production," said Kim Thompson, Kraig Labs CEO and Founder. "Our 2026 roadmap was built around disciplined expansion, operational efficiency, and multi-ton output. Today, that roadmap is in motion. Bio-materials have recently been moved to incubation in preparation for the March production run."
 
The March production run represents the first major deployment under the Company's 2026 plan. The initiative is designed to drive consistent output at levels never before seen, while reinforcing quality control, supply chain stability, and downstream processing capacity.
 
By initiating this production cycle, Kraig Labs is delivering on its commitment, creating the world's first reliable, repeatable, and scalable commercial spider silk manufacturing. The Company's vertically integrated model enables rapid deployment of materials, controlled expansion of silkworm rearing operations, and alignment with future customer demand.
 
"Our focus is clear," Thompson continued. "Execution. Volume. Commercialization. Every production cycle strengthens our position as the global leader in recombinant spider silk."
 
Kraig Labs expects this March run to set the pace for subsequent production cycles throughout 2026, forming the foundation for sustained monthly metric-ton-level spider silk production.

Source:

Kraig Biocraft Laboratories